|
Natural History Study of Smith-Magenis Syndrome Clinical Trials Information presented on Clinical Trials Search isn't designed to be a substitute for certified healthcare advice, travels to or professional assistance using a genuine medical doctor. We are not physicians. Always confer with your dr. about Natural History Study of Smith-Magenis Syndrome conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Natural History Study of Smith-Magenis Syndrome Clinical research trials and Natural History Study of Smith-Magenis Syndrome medical trials happen in hundreds of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually measure the effectualness of new drugs. The intention of the studies / undertakings is to solve certain human healthcare questions. Clinical trials are a popular manner for mDs, government agencies, and private sector companies to locate treatments for all forms of circumstances, such as Natural History Study of Smith-Magenis Syndrome. Natural History Study of Smith-Magenis Syndrome Clinical Trials and other clinical trials allow for volunteers to undergo medical treatment choices before they are available to the general public. Some times the human subjects get treatment for free of charge, and sometimes they are paid for their time. Occasionally there is a cost for a Natural History Study of Smith-Magenis Syndrome clinical trial. Participants frequently get the best healthcare available for their Natural History Study of Smith-Magenis Syndrome condition. Risks are a reality, nonetheless, and can include extra or frequent physician trips, medical risks (possibly life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with exacting guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "N" Clinical Trials Conditions > Natural History Study of Smith-Magenis Syndrome  Natural History Study of Smith-Magenis Syndrome
Natural History Study of Smith-Magenis Syndrome
For Condition: Smith Magenis Syndrome,Chromosome Abnormalities
Status: Recruiting
Sponsor(s): National Human Genome Research Institute (NHGRI) ,
Synopsis: This study will examine how a rare disease called Smith-Magenis syndrome (SMS) affects people and how they change over time. SMS is caused by a small chromosome 17p11.2 deletion (missing piece). The syndrome is associated with distinct physical, developmental and behavioral characteristics, but it is not fully understood. To learn more about this disease, a multidisciplinary research team will study: - The range and type of medical, behavioral, and learning problems of people with SMS - The deletion of chromosome 17p11.2 to find the gene or genes that cause SMS - Whether certain specific genetic changes cause certain specific medical problems - What signs and symptoms must be present to make a diagnosis of SMS - The impact that a child with SMS has on his or her family members. Patients of all ages with SMS may be eligible for this study. They will be evaluated by a team of medical specialists at the NIH Clinical Center over the course of several days. Parents of patients will be asked to provide copies of past medical records and tests results for review. They will provide a family medical history and information on the child's prenatal, developmental, behavioral and medical histories. The study may involve the following evaluations: physical, neurological and psychological exams; ear, nose and throat evaluation; speech, language and swallowing evaluation; hearing test; eye examination; imaging studies (e.g., X-rays, ultrasound, MRI); developmental and behavioral assessment; rehabilitation evaluation with gait (walking) analysis; urinalysis, blood, and/or skin cell studies; sleep study; other consultations as required. A tissue sample (blood or cheek swab or skin biopsy) may be taken for genetic studies. To obtain a cheek swab, a small brush is rubbed against the inside of the cheek to wipe off some cells. For a skin biopsy, a small area of skin is numbed with a local anesthetic and a small circle of skin, usually about 1/8 inch, is removed with a biopsy tool. Parents may be asked to complete questionnaires about their child's growth and development, therapies, medications, sleep, development and behavioral concerns. They also may be asked to bring their child to NIH for follow-up visits every 6 months to 3 years, depending on the child's age. The purpose of these visits is to see how the child changes over time and to conduct additional tests. Parents may also be asked to enroll their child in a SMS Research Registry and provide tissue samples for a SMS Research Core Tissue Bank. The research registry is a confidential database of individuals diagnosed with SMS. Its purpose is to facilitate SMS research initiatives and promote the development of improved treatments for SMS. Enrollment requires completing a 30-minute questionnaire. The tissue bank stores tissue cultures and cell lines created for future SMS research. About 2 teaspoons of blood are drawn from adult patients and 1 to 3 teaspoons from children, depending on their size. Tissue samples can be obtained by skin biopsy or during a scheduled surgical procedure.
Details: This project investigates the clinical manifestations and molecular genetic defects of Smith-Magenis Syndrome (SMS), a rare contiguous gene syndrome caused by interstitial deletion of chromosome 17p11.2. Individuals with confirmed or clinically suspected SMS, and their parents, will be enrolled in this comprehensive longitudinal study. An NIH interdisciplinary SMS Research team (SMS-RT) of clinical and basic science researchers, in collaboration with offsite investigators, will conduct comprehensive clinical and molecular analyses to delineate the physical, biochemical, developmental and neurobehavioral aspects of the syndrome from birth to adulthood. This protocol aims to: characterize the phenotypic variability, natural history and underlying pathophysiology of SMS; delineate the neurobehavioral phenotype with respect to sleep disturbance, cognition, mood and maladaptive behaviors; investigate the physiologic and functional aspects specifically underlying delays in speech/language development; explore genotype/phenotype correlations; develop and evaluate potential sleep and behavioral intervention and therapeutic strategies likely to improve outcome; and evaluate the psychosocial impact of SMS on the family system. Unaffected siblings serve as a comparison group in this study.
Eligibility:
Study Type: Observational, Natural History
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: INCLUSION CRITERIA: Persons with known or suspected SMS and their parents are eligible for enrollment. Persons with Smith-Magenis Syndrome confirmed by deletion of 17p.11.2. Persons with clinical features suggestive of SMS (including midface hypoplasia, prominent forehead, upslanting palpebral fissures, history of infantile hypotonia and /or failure to thrive, early speech/language delay, altered sleep patterns, hoarse deep voice, short stature, brachydactyly, signs of peripheral neuropathy, developmental delay/mental retardation, and/or maladaptive behaviors/autistic like features) in the absence of cytogenetic confirmation of deletion 17p.11.2, and who test negative for other known genetic disorders that overlap with SMS. Male or female, all ages, all ethnicities. Parents of persons with known or suspected SMS. Unaffected sibling or normal twin or sibling to the SMS proband (sibling control). SMS RESEARCH REGISTRY AND CORE TISSUE BANK INCLUSION CRITERIA: Individuals (male and female, all ages and all ethnicities) with a confirmed diagnosis of SMS and their parents who voluntarily give informed consent. EXCLUSION CRITERIA: Inability to obtain informed consent. Persons with confirmed cytogenetic diagnosis of trisomy 21, Prader-Willi Syndrome (del 15q), Angelman Syndrome (del 15q), and Velocardiofacial Syndrome (del 22q); molecular confirmation of Fragile X Syndrome or other recognized multiple congenital anomaly/MR syndrome. Subjects may be excluded from further participation if the diagnosis of SMS is ruled out as a result of the initial screening evaluation. SMS RESEARCH REGISTRY AND CORE TISSUE BANK EXCLUSION CRITERIA: Individuals who do not have confirmed diagnosis of SMS.
Total Enrollment: 600
Location and Contact Information:
National Human Genome Research Institute (NHGRI) *Recruiting*
Bethesda, Maryland, 20892
United States
Recruiting Patient and Public Liaison Office 1-800-411-1222
Additional Information:
Study ID Numbers: 010109; 01-HG-0109
Study Start Date: March 13, 2001
Record last reviewed: February 27, 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00013559
Other Chromosome Abnormalities Studies:
1. Immunologic Evaluation in Patients With DiGeorge Syndrome or Velocardiofacial Syndrome
2. Study of Phenotype and Genotype Correlations in Patients With Contiguous Gene Deletion Syndromes
3. Down Syndrome - Comparison of Screening Methods in the 1st and 2nd Trimesters
4. Natural History Study of Smith-Magenis Syndrome
Related Studies:
Other Chromosome Abnormalities Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials
Natural History Study of Smith-Magenis Syndrome
|
|
|
|
|
|
|
|
